Arkolith/Insider Trading/FBLG/Form 4

Davis Jason

Chief Financial OfficerFibroBiologics, Inc. (FBLG) · full profile →Form 4 · filed Mar 3, 2026
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Buy(P)70K$0.41$29K70K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-008646) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML